New hope for Hard-to-Treat blood cancers: mirdametinib trial opens
NCT ID NCT07061951
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 32 times
Summary
This study tests a drug called mirdametinib in 20 people whose chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) has returned or not responded to prior treatments. The drug blocks a protein that helps cancer cells grow, aiming to shrink tumors or slow the disease. Participants will take the drug by mouth and be monitored for side effects and how well the cancer responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Comprehensive Cancer Center
RECRUITINGDuarte, California, 91010, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
City of Hope at Irvine Lennar
RECRUITINGIrvine, California, 92618, United States
Contact
Contact Phone: •••-•••-••••
-
UNC Lineberger Comprehensive Cancer Center
RECRUITINGChapel Hill, North Carolina, 27599, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.